BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11196465)

  • 1. Role of ERK/MAP kinase in mitogenic interaction between ACTH and FGF2 in mouse Y1 adrenocortical tumor cells.
    Lotfi CF; Costa ET; Schwindt TT; Armelin HA
    Endocr Res; 2000 Nov; 26(4):873-7. PubMed ID: 11196465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction in G0/G1-arrested mouse Y1 adrenocortical cells stimulated by ACTH and FGF2.
    Lepique AP; Forti FL; Moraes MS; Armelin HA
    Endocr Res; 2000 Nov; 26(4):825-32. PubMed ID: 11196459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing the molecular mechanisms of cell cycle control in a mouse adrenocortical cell line: roles of ACTH.
    Rocha KM; Forti FL; Lepique AP; Armelin HA
    Microsc Res Tech; 2003 Jun; 61(3):268-74. PubMed ID: 12768542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine vasopressin inhibition of cyclin D1 gene expression blocks the cell cycle and cell proliferation in the mouse Y1 adrenocortical tumor cell line.
    Schwindt TT; Forti FL; Juliano MA; Juliano L; Armelin HA
    Biochemistry; 2003 Feb; 42(7):2116-21. PubMed ID: 12590600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative signaling initiated in ACTH receptors.
    Lotfi CF; Lepique AP; Forti FL; Schwindt TT; Eichler CB; Santos MO; Rebustini IT; Hajj GN; Juliano L; Armelin HA
    Braz J Med Biol Res; 2000 Oct; 33(10):1133-40. PubMed ID: 11004713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc protein is stabilized by fibroblast growth factor 2 and destabilized by ACTH to control cell cycle in mouse Y1 adrenocortical cells.
    Lepique AP; Moraes MS; Rocha KM; Eichler CB; Hajj GN; Schwindt TT; Armelin HA
    J Mol Endocrinol; 2004 Dec; 33(3):623-38. PubMed ID: 15591023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cell cycle control in the mouse Y1 adrenal cell line.
    Costa ET; Forti FL; Rocha KM; Moraes MS; Armelin HA
    Endocr Res; 2004 Nov; 30(4):503-9. PubMed ID: 15666780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between the growth regulatory pathways in primary rat adrenal cells and mouse tumor cell line.
    Mattos GE; Lotfi CF
    Mol Cell Endocrinol; 2005 Dec; 245(1-2):31-42. PubMed ID: 16289304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cfos and cjun antisense oligonucleotides block mitogenesis triggered by fibroblast growth factor-2 and ACTH in mouse Y1 adrenocortical cells.
    Lotfi CF; Armelin HA
    J Endocrinol; 2001 Mar; 168(3):381-9. PubMed ID: 11241169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the adrenocortical cell cycle: interaction between FGF2 and ACTH.
    Armelin HA; Lotfi CF
    Braz J Med Biol Res; 1999 Jul; 32(7):841-3. PubMed ID: 10454742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells.
    Lotfi CF; Todorovic Z; Armelin HA; Schimmer BP
    J Biol Chem; 1997 Nov; 272(47):29886-91. PubMed ID: 9368063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Fos protein is a mediator in mitogenic response to ACTH.
    Lotfi CF; Armelin HA
    Endocr Res; 1998; 24(3-4):421-4. PubMed ID: 9888518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Jun/Fos protein localization and DNA synthesis in rat adrenal cortex after treatment with ACTH or FGF2.
    Baccaro RB; Mendonça PO; Torres TE; Lotfi CF
    Cell Tissue Res; 2007 Apr; 328(1):7-18. PubMed ID: 17216194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine vasopressin controls p27(Kip1) protein expression by PKC activation and irreversibly inhibits the proliferation of K-Ras-dependent mouse Y1 adrenocortical malignant cells.
    Forti FL; Armelin HA
    Biochim Biophys Acta; 2011 Aug; 1813(8):1438-45. PubMed ID: 21571010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH promotion of p27(Kip1) induction in mouse Y1 adrenocortical tumor cells is dependent on both PKA activation and Akt/PKB inactivation.
    Forti FL; Schwindt TT; Moraes MS; Eichler CB; Armelin HA
    Biochemistry; 2002 Aug; 41(31):10133-40. PubMed ID: 12146978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of ERK activity in the regulation of cyclin D1 levels and DNA synthesis in human cultured airway smooth muscle.
    Ravenhall C; Guida E; Harris T; Koutsoubos V; Stewart A
    Br J Pharmacol; 2000 Sep; 131(1):17-28. PubMed ID: 10960064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK1/2 and JNK signaling synergistically modulate mitogenic effect of fibroblast growth factor 2 on liver cell.
    Wu S; Zhang W; Ma S; Li B; Xu C; Yi P
    Cell Biol Int; 2018 Nov; 42(11):1511-1522. PubMed ID: 30080297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation of MAPKs in Y1 mouse adrenocortical tumor cells.
    Le T; Schimmer BP
    Endocrinology; 2001 Oct; 142(10):4282-7. PubMed ID: 11564685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
    Dell'Era P; Mohammadi M; Presta M
    Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.